If the treatment is a drug that has not been approved by the Food and Drug Administration or has not been specifically approved for a child's particular disease, then insurance companies typically will not cover it because the treatment is considered 'off-label' or 'experimental.'
Hagan discusses insurance challenges for unapproved treatments for children.
Share
More from Kay Hagan
I am pleased that the strategy that the administration has developed for defeating ISIS does include the training and equipping the moderate Syrian opposition.
As you and I have both specified, and other folks have, too, 12 percent of workers overall have paid family leave.
I think that's very important, because it certainly would degrade their capability.
Other voices in this conversation
